Kodiak Sciences Inc.
corporate_fare Company Profile
Kodiak Sciences Inc. (NASDAQ:KOD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 18 items for KOD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 8/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for KOD spans 8-K, 4, S-3ASR, 10-Q.
Recent high-impact activity:
- Kodiak Q3 Loss Widens to $66.2M; $69M ATM Raise Extends Runway Into 2027
- Q3 Loss Widens to $66.2M as Kodiak Raises $69M Through ATM Sales
- Baker Bros. Buys $24.3M of Kodiak Sciences at $98.51, Adding to 20.4M-Share Stake
- Kodiak Files New $350M At-The-Market Program With J.P. Morgan
- Baker Bros. Adds $58.6M Kodiak Sciences Stake After Phase 3 Win
Financial Snapshot
Short Interest & Short Volume
9.34 days to coverFINRA reported short interest of 8,115,058 shares in KOD as of the October 30, 2026 settlement, a 4.5% decrease from the prior period — about 9.3 days to cover at its recent average daily volume. On November 20, 2026, 58.5% of KOD volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Moderate riskFiling-implied dilution signals for KOD, detected from its recent SEC filings · based on capital-structure filings through 2026-10-20.
New $350M ATM Program Established · Dilution If Fully Drawn
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →